Reprogramming of central carbon metabolism in hepatocellular carcinoma

被引:20
作者
Xia, Haoming [1 ]
Huang, Ziyue [1 ]
Xu, Yi [1 ,2 ,3 ]
Yam, Judy Wai Ping [3 ]
Cui, Yunfu [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 2, Dept Hepatopancreatobiliary Surg, Harbin 150086, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Key Lab Myocardial Ischem, Minist Educ, Harbin 150086, Heilongjiang, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong 999077, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Hepatocellular carcinoma; Metabolic reprogramming; Tumor microenvironment; Environmental stress; Cancer stem cell; Energy stress; GLUCOSE-METABOLISM; MITOCHONDRIAL DYSFUNCTION; TUMOR METABOLISM; PYRUVATE-KINASE; CELL-SURVIVAL; COPY NUMBER; CANCER; GROWTH; AUTOPHAGY; EXPRESSION;
D O I
10.1016/j.biopha.2022.113485
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In multicellular organisms, nutrient uptake and its metabolism are subject to stringent regulation to maintain cellular integrity and prevent aberrant cell proliferation. However, the altered signaling pathways and gene expression disorders in hepatocellular carcinoma (HCC) induce the transformation of metabolic patterns. The reprogrammed metabolic pattern not only conferred HCC cells viability in nutrient-deficient environments, but also contributed to the formation of a unique immune surveillance barrier. Furthermore, in this metabolic pattern, the accumulation of a large number of oxidation products in cells also activates tumor-related signaling pathways. Therefore, the exploration of underlying molecular mechanisms of the metabolic switch will help to improve therapeutic strategies for HCC. We systematically reviewed the landmark events and current research breakthroughs in the study of glucometabolic reprogramming in HCC. Focusing on the central carbon metabolism, the internal energy conversion in HCC and its cancerous mechanisms were fully explained. Furthermore, we also discussed the HCC-specific acellular regulation, metabolic switch of cancer stem cells, oxidative stress adaptation and the formation of immunosuppressive microenvironment, hoping to provide insights for future basic and clinical research.
引用
收藏
页数:12
相关论文
共 152 条
[1]   Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma Phase 3 CALGB 80802 Randomized Clinical Trial [J].
Abou-Alfa, Ghassan K. ;
Shi, Qian ;
Knox, Jennifer J. ;
Kaubisch, Andreas ;
Niedzwiecki, Donna ;
Posey, James ;
Tan, Benjamin R., Jr. ;
Kavan, Petr ;
Goel, Rakesh ;
Lammers, Philip E. ;
Bekaii-Saab, Tanios S. ;
Tam, Vincent C. ;
Rajdev, Lakshmi ;
Kelley, Robin K. ;
El Dika, Imane ;
Zemla, Tyler ;
Potaracke, Ryan, I ;
Balletti, Jennifer ;
El-Khoueiry, Anthony B. ;
Harding, James H. ;
Suga, Jennifer M. ;
Schwartz, Lawrence H. ;
Goldberg, Richard M. ;
Bertagnolli, Monica M. ;
Meyerhardt, Jeffrey ;
O'Reilly, Eileen M. ;
Venook, Alan P. .
JAMA ONCOLOGY, 2019, 5 (11) :1582-1588
[2]   Glucose transporters in cancer metabolism [J].
Adekola, Kehinde ;
Rosen, Steven T. ;
Shanmugam, Mala .
CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) :650-654
[3]   Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis [J].
Anastasiou, Dimitrios ;
Yu, Yimin ;
Israelsen, William J. ;
Jiang, Jian-Kang ;
Boxer, Matthew B. ;
Hong, Bum Soo ;
Tempel, Wolfram ;
Dimov, Svetoslav ;
Shen, Min ;
Jha, Abhishek ;
Yang, Hua ;
Mattaini, Katherine R. ;
Metallo, Christian M. ;
Fiske, Brian P. ;
Courtney, Kevin D. ;
Malstrom, Scott ;
Khan, Tahsin M. ;
Kung, Charles ;
Skoumbourdis, Amanda P. ;
Veith, Henrike ;
Southall, Noel ;
Walsh, Martin J. ;
Brimacombe, Kyle R. ;
Leister, William ;
Lunt, Sophia Y. ;
Johnson, Zachary R. ;
Yen, Katharine E. ;
Kunii, Kaiko ;
Davidson, Shawn M. ;
Christofk, Heather R. ;
Austin, Christopher P. ;
Inglese, James ;
Harris, Marian H. ;
Asara, John M. ;
Stephanopoulos, Gregory ;
Salituro, Francesco G. ;
Jin, Shengfang ;
Dang, Lenny ;
Auld, Douglas S. ;
Park, Hee-Won ;
Cantley, Lewis C. ;
Thomas, Craig J. ;
Heiden, Matthew G. Vander .
NATURE CHEMICAL BIOLOGY, 2012, 8 (10) :839-847
[4]   Oncogenic Roles of the PI3K/AKT/mTOR Axis [J].
Aoki, Masahiro ;
Fujishita, Teruaki .
VIRUSES, GENES, AND CANCER, 2017, 407 :153-189
[5]  
Aspuria PJP, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-21
[6]   Metabolic Reprogramming of Immune Cells in Cancer Progression [J].
Biswas, Subhra K. .
IMMUNITY, 2015, 43 (03) :435-449
[7]   Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial [J].
Bruix, Jordi ;
Qin, Shukui ;
Merle, Philippe ;
Granito, Alessandro ;
Huang, Yi-Hsiang ;
Bodoky, Gyrogy ;
Pracht, Marc ;
Yokosuka, Osamu ;
Rosmorduc, Olivier ;
Breder, Valeriy ;
Gerolami, Rene ;
Masi, Gianluca ;
Ross, Paul J. ;
Song, Tianqiang ;
Bronowicki, Jean-Pierre ;
Ollivier-Hourmand, Isabelle ;
Kudo, Masatoshi ;
Cheng, Ann-Lii ;
Llovet, Josep M. ;
Finn, Richard S. ;
LeBerre, Marie-Aude ;
Baumhauer, Annette ;
Meinhardt, Gerold ;
Han, Guohong .
LANCET, 2017, 389 (10064) :56-66
[8]   Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of Metabolism [J].
Cai, Ling-Yan ;
Chen, Shi-Jie ;
Xiao, Sen-Hao ;
Sun, Qin-Juan ;
Ding, Chen-Hong ;
Zheng, Bai-Nan ;
Zhu, Xin-Yan ;
Liu, Shu-Qing ;
Yang, Feng ;
Yang, Ya-Xi ;
Zhou, Bing ;
Luo, Cheng ;
Zhang, Xin ;
Xie, Wei-Fen .
CANCER RESEARCH, 2021, 81 (04) :860-872
[9]   Cancer stem cell metabolism: target for cancer therapy [J].
Chae, Young Chan ;
Kim, Jae Ho .
BMB REPORTS, 2018, 51 (07) :319-326
[10]   E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing [J].
Chen, De ;
Wang, Yanjie ;
Lu, Ruixun ;
Jiang, Xiaofeng ;
Chen, Xinhui ;
Meng, Nan ;
Chen, Min ;
Xie, Shan ;
Yan, Guang-Rong .
THERANOSTICS, 2020, 10 (19) :8558-8572